Cunningham Ann Michelle 4
4 · Vistagen Therapeutics, Inc. · Filed Mar 6, 2024
Insider Transaction Report
Form 4
Cunningham Ann Michelle
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-03-04+12,500→ 12,500 totalExercise: $4.85Exp: 2034-03-04→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]Represents stock options granted pursuant to the Issuer's Amended and Restated 2019 Omnibus Equity Incentive Plan, as amended, which vest in twelve equal monthly installments, beginning on the date of the grant.